Genomics and Personalized Medicine

基因组学和个性化医疗

• 批准号: 9042805
• 负责人: DAVID L. WOODLAND
• 金额: $ 1.5万
• 依托单位: KEYSTONE SYMPOSIA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9042805
• 关键词: Address; Adult; Alberta province; Area; Basic Science; Big Data; Biology; Businesses; Canada; Cancer Patient; Child; Clinical; Collaborations; Computers; DNA Sequence; Data; Development; Disease; Disease susceptibility; Engineering; Future; Genome; Genomics; Goals; Health; Healthcare; Human; Individual; Knowledge; Learning; Malignant Neoplasms; Medicine; Metagenomics; Methodology; Minor; Outcome; Patients; Play; Policies; Proteomics; Research; Research Personnel; Role; Scientist; Technology; Translational Research; Work; cancer genome; clinical practice; disease diagnosis; epigenomics; genome sequencing; human disease; improved; individualized medicine; infancy; interest; meetings; metabolomics; new technology; novel strategies; personalized genomic medicine; personalized health care; personalized medicine; posters; precision medicine; public health relevance; sensor; symposium; technology development; transcriptomics; uptake

 DESCRIPTION (provided by applicant): Support is requested for a Keystone Symposia meeting entitled Genomics and Personalized Medicine, organized by Michael Snyder, Leroy E. Hood and Heidi L. Rehm. The meeting will be held in Banff, Alberta, Canada from February 7-11, 2016. Genomics and other omics technologies are playing an increasingly important role in health care, and new sensors are being developed to help manage personal health. Spurred by the revolution in DNA sequencing technologies, it is now possible to sequence the genome of patients with cancer, undiagnosed disease and even healthy individuals to help tailor treatment for a specific individual's disease. This entire area is moving extremely rapidly in terms of technology, data, its management and analysis, and clinical uptake. The goal of this meeting is to bring together leaders in technology development, basic scientists, engineers and clinicians to advance human health. The conference intends to: 1) Help researchers and clinicians keep abreast of the latest developments; 2) Stimulate collaborations; and 3) Spur the development of new technologies that will improve personalized medicine. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on The Cancer Genome, which will share a keynote address and three plenary sessions with this meeting.

 描述（由申请人提供）：支持被要求为一个基石研讨会会议，题为基因组学和个性化医疗，由迈克尔斯奈德，勒罗伊E。Hood和Heidi L.雷姆。会议将于2016年2月7日至11日在加拿大阿尔伯塔省班夫市举行。基因组学和其他组学技术在医疗保健中发挥着越来越重要的作用，新的传感器正在开发，以帮助管理个人健康。在DNA测序技术革命的推动下，现在可以对癌症患者、未确诊疾病甚至健康个体的基因组进行测序，以帮助针对特定个体的疾病进行量身定制的治疗。整个领域在技术、数据、管理和分析以及临床应用方面都在迅速发展。本次会议的目标是汇集技术开发领导者，基础科学家，工程师和临床医生，以促进人类健康。会议打算：1）帮助研究人员和临床医生了解最新发展; 2）促进合作; 3）促进新技术的发展，以改善个性化医疗。跨学科互动的机会将显着提高同期会议的癌症基因组，这将分享一个主旨演讲和三个全体会议与本次会议。